Table 3 Laboratory values of patients with sJIA at pre-MAS, onset of MAS and after treatment of-MAS. (n = 34)
Laboratory variables | pre-MAS | post-MAS | Post treatment-MAS | |||
|---|---|---|---|---|---|---|
n | Median(IQR) | n | Median(IQR) | n | Median(IQR) | |
WBC (×109/L) | 33 | 14.47(10.25–20.78) | 34 | 7.76(5.54–16.32) | 34 | 12.6(8.83–23.03) |
Hb (g/L) | 33 | 104(98.5-112.5) | 34 | 101(92–112) | 34 | 104.5(96-111.8) |
PLT (×109/L) | 33 | 258(210–396)* | 34 | 136(99.75–237.8) | 34 | 391.5(215–472) |
CRP (mg/L) | 32 | 64.5(25-97.25) | 34 | 25.5(8-62.5) | 34 | 8(8–12) |
ESR (mm/h) | 29 | 64(40-85.5)* | 28 | 30(18.25–37.83) | 28 | 16.5(8.25–35.5) |
Alb (g/L) | 28 | 35.05(32.8537.83) | 34 | 33.5(31.78–36.18) | 34 | 37.7(35.1-41.55) |
ALT (U/L) | 32 | 28.85(13-135.5)* | 34 | 281(61.75–698.3) | 34 | 110.5(43.75–205.3) |
AST (U/L) | 32 | 45(26.5-91.25)* | 34 | 191(83.75–541.5) | 34 | 33(24.75–56.25) |
LDH (U/L) | 29 | 472(302–611)* | 34 | 825.5(609–1420) | 34 | 382.5(301.8-492.3) |
TG (mmol/L) | 28 | 1.40(1.17–2.03) | 34 | 2.04(1.48–2.42) | 34 | 2.36(1.56–3.55) |
Dimer (mg/L) | 22 | 1174(584–2517)* | 28 | 2199(664.3–7280) | 27 | 292(180–521) |
FIB (g/L) | 25 | 3.58(2.82–4.89)* | 31 | 2.43(1.6–2.71) | 30 | 2.13(1.43–3.87) |
SF (µg/L) | 29 | 1500(854.5–2146)* | 34 | 11,014(5546–22,930) | 34 | 1887(740.5–3637) |
SF/ESR | 28 | 24.98(15.76–40.95)* | 27 | 411.1(106.6-709.3) | 28 | 89.41(32.75–130.3) |